Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Valsartan × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Heart Failure 1

Interventions

pembrolizumab 540 Specimen Handling 507 Magnetic Resonance Spectroscopy 437 Carboplatin 351 Cyclophosphamide 333 Biopsy 304 Cisplatin 295 Paclitaxel 265 Nivolumab 253 Gemcitabine 228 Radiotherapy 222 Bevacizumab 193 Dexamethasone 190 fludarabine 183 venetoclax 178 Oxaliplatin 158 Docetaxel 156 Fluorouracil 154 atezolizumab 153 durvalumab 151 Rituximab 148 Capecitabine 143 Pemetrexed 142 Doxorubicin 134 Radiation 130 Lenalidomide 128 Prednisone 124 Standard of Care 122 Radiosurgery 118 Drug Therapy 117

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05194111 2026-03-13

TREAT-HF

Virginia Commonwealth University

Phase 1/2 Recruiting

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡